article thumbnail

Carnage in the bond market again with benchmark ETF down 10% on year to lowest since 2011

CNBC: Investing

10, 2011. The iShares 20+ Year Treasury Bond ETF (TLT) closed at $89.18 on Monday, which was its lowest close since Feb.

IT 106
article thumbnail

‘Vindicating’: An Analyst Who Lowered the U.S.’s Credit Rating in 2011 on Fitch’s Downgrade

The New York Times: Banking

Nikola Swan played a key role at S&P when the agency became the first to strip America of its top ranking in 2011.

S&P 79
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘Vindicating’: An Analyst Who Lowered the U.S.’s Credit Rating in 2011 on Fitch’s Downgrade

The New York Times: Banking

Nikola Swan played a key role at S&P when the agency became the first to strip America of its top ranking in 2011.

S&P 79
article thumbnail

UK house prices post biggest annual drop since 2011: Halifax

Global Banking & Finance

UK house prices post biggest annual drop since 2011: Halifax By Andy Bruce LONDON (Reuters) -British house prices fell last month in annual terms at the fastest rate in 12 years and soaring interest rates are likely to herald more weakness in the housing market, mortgage lender Halifax said on Friday. House prices dropped 2.6% […]

52
article thumbnail

AIFMD II – What EU and non-EU fund managers need to know

JD Supra: Mergers

In order to harmonize the regulatory framework governing the European fund market, the European Commission has revised the existing Alternative Investment Fund Manager Directive – Directive 2011/61/EU (the "AIFMD"), with the introduction of the Alternative Investment Fund Manager Directive II ("AIFMD II"). By: Mayer Brown

Funds 183
article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Linden Acquires Alcresta Therapeutics

JD Supra: Mergers

Alcresta, founded in 2011 and based in Newton, Mass., Linden Capital Partners has announced the acquisition of Alcresta Therapeutics. develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. By: McGuireWoods LLP

article thumbnail

Bill Ackman lays out a series of reasons why he's betting rates keep rising — How you can play along

CNBC: Investing

The 30-year Treasury yield hit its highest level since 2011 on Thursday, and Ackman is betting that it will continue to rise.

IT 121